Get the Stockscreener App
3.74
6.03%
-0.24
After Hours:
3.94
0.20
+5.35%
Trevena Inc stock is traded at $3.74, with a volume of 31,262.
It is down -6.03% in the last 24 hours and down -5.08% over the past month.
Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.
See More
Previous Close:
$3.98
Open:
$4.0232
24h Volume:
31,262
Relative Volume:
0.13
Market Cap:
$3.19M
Revenue:
$3.13M
Net Income/Loss:
$-40.29M
P/E Ratio:
-0.8348
EPS:
-4.48
Net Cash Flow:
$-33.08M
1W Performance:
+1.08%
1M Performance:
-5.08%
6M Performance:
+713.04%
1Y Performance:
+520.23%
1-Day Range:
$3.70
$4.04
1-Week Range:
$3.61
$4.34
52-Week Range:
$0.1703
$7.85
Trevena Inc Stock (TRVN) Company Profile
Name
Trevena Inc
Sector
Industry
Phone
(610) 354-8840
Address
955 CHESTERBROOK BOULEVARD, CHESTERBROOK, PA
Trevena Inc Stock (TRVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-15-21 | Initiated | Oppenheimer | Perform |
| Sep-14-20 | Initiated | Guggenheim | Buy |
| Aug-28-20 | Initiated | Cantor Fitzgerald | Overweight |
| May-31-19 | Resumed | H.C. Wainwright | Buy |
| Nov-05-18 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-12-18 | Downgrade | Needham | Buy → Hold |
| Oct-10-18 | Downgrade | Jefferies | Buy → Hold |
| Nov-08-17 | Reiterated | Needham | Buy |
| Oct-16-17 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-12-17 | Reiterated | H.C. Wainwright | Buy |
| May-08-17 | Reiterated | Needham | Buy |
| Feb-23-17 | Reiterated | H.C. Wainwright | Buy |
| Feb-22-17 | Reiterated | FBR & Co. | Outperform |
| Feb-02-17 | Initiated | Ladenburg Thalmann | Buy |
| Jan-09-17 | Initiated | H.C. Wainwright | Buy |
| Jan-05-17 | Initiated | Oppenheimer | Outperform |
| May-17-16 | Reiterated | FBR Capital | Outperform |
| May-17-16 | Reiterated | Needham | Buy |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Sep-01-15 | Reiterated | Wedbush | Outperform |
| Aug-03-15 | Initiated | Brean Capital | Buy |
View All
Trevena Inc Stock (TRVN) Latest News
Trevena's SWOT analysis: stock outlook amid pipeline progress, strategic shifts - Investing.com UK
Anitra (AMEX:AZTR) Stock Quotes, Forecast and News Summary - Benzinga
Oragenics (AMEX:OGEN) Stock Quotes, Forecast and News Summary - Benzinga
Palisade Bio (NASDAQ:PALI) Stock Quotes, Forecast and News Summary - Benzinga
Short Interest in TrueCar, Inc. (NASDAQ:TRUE) Rises By 20.1% - Defense World
AGBA Group Holding Limited (NASDAQ:AGBAW) Short Interest Update - Defense World
Smith & Nephew (LON:SN) Stock Price Passes Above 200-Day Moving Average of $1,055.41 - Defense World
MAG Silver Corp. (TSE:MAG) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Aimei Health Technology Co., Ltd (NASDAQ:AFJK) Sees Large Drop in Short Interest - Defense World
Occidental Petroleum Corp WT (NYSE:OXY.W) Stock Price Up 1.1% - Defense World
INmune Bio, Inc. (NASDAQ:INMB) CEO Raymond Joseph Tesi Purchases 15,380 Shares - Defense World
Principal Financial Group Inc. Makes New $88,000 Investment in Cipher Mining Inc. (NASDAQ:CIFR) - Defense World
Klaviyo, Inc. (NYSE:KVYO) Major Shareholder Summit Partners L. P Sells 107,205 Shares of Stock - Defense World
Pure Storage, Inc. (NYSE:PSTG) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Molina Healthcare, Inc. (NYSE:MOH) Given Consensus Rating of “Hold” by Brokerages - Defense World
Franklin Resources, Inc. (NYSE:BEN) Receives Consensus Recommendation of “Reduce” from Brokerages - Defense World
Fluor Co. (NYSE:FLR) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
O-I Glass, Inc. (NYSE:OI) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Allient Inc. (NASDAQ:ALNT) Sees Significant Decline in Short Interest - Defense World
Learn to Evaluate (TRVN) using the Charts - Stock Traders Daily
Trevena (NASDAQ:TRVN) Stock Price Crosses Below Two Hundred Day Moving Average of $8.53 - MarketBeat
Trevena (NASDAQ:TRVN) Coverage Initiated by Analysts at StockNews.com - MarketBeat
Trevena Inc’s Shares Reel: -18.63% Quarterly Revenue Decline Amid 6.66M Market Cap - The InvestChronicle
Medical Marijuana Market to Grow by USD 39.8 Billion (2024-2028), Driven by Product Launches, How AI is Shaping the MarketTechnavio Report - The Malaysian Reserve
Medical Marijuana Market to Grow by USD 39.8 Billion (2024-2028), Driven by Product Launches, How AI is Shaping the MarketTechnavio Report - Lelezard
Medical Marijuana Market To Grow By USD 39.8 Billion (2024-2028), Driven By Product Launches, How AI Is Shaping The MarketTechnavio Report - MENAFN.COM
Medical Marijuana Market to Grow by USD 39.8 Billion (2024-2028), Driven by Product Launches, How AI is Shaping the MarketTechnavio Report - PR Newswire
Medical Marijuana Market to Grow by USD 39.8 Billion (2024-2028), Driven by Product Launches, How AI is Shaping the MarketTechnavio Report - Yahoo Finance
Short Interest in Trevena, Inc. (NASDAQ:TRVN) Declines By 28.0% - MarketBeat
Trevena (STU:6T4) Net-Net Working Capital : €-27.81 (As of Jun. 2024) - GuruFocus.com
Trevena regains Nasdaq compliance, seeks equity requirement extension By Investing.com - Investing.com Canada
Trevena regains Nasdaq compliance, seeks equity requirement extension - Investing.com
Opioid Drugs Market Outlook, Growth By Top Companies, Applications, Drivers, Trends & Forecast - WhaTech Technology and Markets News
Analyzing Trevena (NASDAQ:TRVN) and KALA BIO (NASDAQ:KALA) - Defense World
TRVN (Trevena) Cash From Other Investing Activities : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com
Trevena, Inc. (NASDAQ:TRVN) Sees Large Drop in Short Interest - MarketBeat
Trevena stock plunges to 52-week low, now at $5.13 By Investing.com - Investing.com Canada
Trevena stock plunges to 52-week low, now at $5.13 - Investing.com
Trevena stock plunges to 52-week low, now at $5.13 By Investing.com - Investing.com UK
Trevena Announces Reverse Stock Split to Regain Nasdaq Compliance - MSN
Trevena Inc (TRVN) presents a great opportunity, but the stock is slightly undervalued - US Post News
StockNews.com Begins Coverage on Trevena (NASDAQ:TRVN) - Defense World
Trevena Announces Reverse Stock Split to Regain Nasdaq Compliance - MyChesCo
Trevena (NASDAQ:TRVN) Shares to Reverse Split on Tuesday, August 13th - Defense World
Trevena Second Quarter 2024 Earnings: US$0.23 loss per share (vs US$0.69 loss in 2Q 2023) - Simply Wall St
Navigating Trevena’s Potential: Buy, Sell, or Hold? - MyChesCo
Trevena Inc expected to post a loss of 29 cents a shareEarnings Preview - XM
Company’s Banking Stock: Dissecting a -46.01% Quarterly Revenue Decline Amid Growth - The InvestChronicle
Trevena announces 1-for-25 reverse stock split By Investing.com - Investing.com Canada
Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket - Benzinga
Trevena: Q2 Earnings Snapshot - CT Insider
Trevena Inc Stock (TRVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):